VEGFA and ischemia: In contrast to promising results from animal studies, administration of proangiogenic factors such as fibroblast growth factor (FGF) or vascular endothelial growth factor (VEGF) failed to induce significant improvement in ischemia in several phase 1 clinical trials1, making research into new strategies necessary.